tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corinne Jenkins, 47 are a BUY (55.29%), 28 are a HOLD (32.94%), 10 are a SELL (11.76%).
Analyst Corinne Jenkins, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 63.2% that have a potential upside of 30.67% achieved within 160 days.
Corinne Jenkins’s has documented 172 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RYTM, Rhythm Pharmaceuticals at 05-Dec-2024.
Analyst best performing recommendations are on AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES) at 9/13/2023. The price target of $10 was fulfilled within 1 day with a profit of $1.16 (10.39%) receiving and performance score of 103.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 months 28 days ago
(02-Dec-2024)
2/2 (100%)
$23.43 (108.62%)
1555
Hold
$17.5
10 months ago
(30-May-2024)
1/1 (100%)
$-2.14 (-10.90%)
19
Hold
2 years 9 months 6 days ago
(24-Jun-2022)
9/9 (100%)
$-24.19 (-54.74%)
596
Hold
$10
$-17.85 (-64.09%)
$7
2 years 9 months 6 days ago
(24-Jun-2022)
1/2 (50%)
$0.43 (7.40%)
15
Sell
$8
$-19.85 (-71.27%)
$16
2 years 9 months 22 days ago
(08-Jun-2022)
2/2 (100%)
$0.9 (8.53%)
132
Which stock is Corinne Jenkins is most bullish on?
Which stock is Corinne Jenkins is most reserved on?
What Year was the first public recommendation made by Corinne Jenkins?
